Related Experiment Video

Updated: Jun 12, 2026

Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model
09:15

Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model

Published on: November 5, 2011

Developing a case study model for successful translation of stem cell therapies

Alan Trounson1, Elona Baum, Don Gibbons

  • 1California Institute for Regenerative Medicine, San Francisco, CA 94107, USA. atrounson@cirm.ca.gov

Cell Stem Cell
|June 24, 2010
PubMed

Insights

California is pioneering novel public-private partnerships to advance cell therapies from pluripotent stem cells. These "disease teams" aim to overcome regulatory hurdles for clinical translation.

Area of Science:

  • Biomedical Science
  • Regenerative Medicine
  • Cell Therapy Development

Background:

  • Pluripotent stem cell-derived therapies show promise but face significant translation challenges.
  • Navigating complex regulatory pathways is a major barrier to clinical development.

Purpose of the Study:

  • To introduce a novel framework for accelerating cell therapy translation.
  • To facilitate the evaluation of new clinical opportunities within regulatory constraints.

Main Methods:

  • Establishment of global public-private "disease team" partnerships.
  • Collaborative approach involving diverse stakeholders to address translational barriers.

Main Results:

  • A new model for partnership formation is proposed.
  • The framework aims to streamline the evaluation of cell therapy candidates.

Conclusions:

  • Public-private partnerships are crucial for overcoming cell therapy translation challenges.
  • This initiative offers a strategic approach to navigate regulatory environments and advance clinical opportunities.

More Related Videos

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats09:31

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model09:57

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Published on: June 4, 2017

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...